Furthermore, whole genome microarray analysis indicated that Sox2OT is differentially expressed in early and late stages of the disease in an AD model mouse, suggesting that Sox2OT might be related to the AD pathobiology (Arisi et al., 2011[8]). Here, SOX2-OT is linked to Alzheimer disease.